The abstract is read at the publisher; the summary is JClub's.
Human blood across two biobank cohorts (~6,000 individuals) is organized into recurrent archetypal cellular states, including three major composition archetypes and two minor interferon/inflammation-linked extremes.
- Why it matters: Blood immune-cell heterogeneity lacks clear organising principles, and the extremes of variation across individuals are not well defined for linking composition to disease risk and therapy response.
- What they did: Using single-cell transcriptomics, the study defines archetypes from coordinated cell-composition patterns, then builds cell2clone to infer lymphocyte clonal expansions and ArcheTypist to classify infection and cancer immunotherapy outcomes.
- The result: Reactive clonal processes are linked to the cytotoxic archetype, premalignant CD5+ B-cell clonal expansion is linked to the CD5+ B-cell archetype, and archetypes are associated with disease risk, clinical blood counts, and immunotherapy outcome classification.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.